Class I recall: American Regent, Inc.: Epinephrine Injection, USP, 30 mg/30 mL (1mg/mL), 30 mL-Multiple-Dose Vial, Rx O
American Regent, Inc. has issued a Class I recall for Epinephrine Injection, USP, 30 mg/30 mL (1mg/mL), 30 mL multiple-dose vials, NDC 0517-3030-01, due to presence of particulate matter and lack of assurance of sterility. The recall notice specifies particulate matter identified as nylon, cellulosic, acrylic, polyethylene, and glass, along with reports of broken and leaking vials.
Most relevant for: Clinicians who stock or administer this specific lot of multiple-dose epinephrine vials for intravenous, intramuscular, or subcutaneous use, including in obstetric emergency settings.
Read the original at FDA Drug Enforcement ReportsSummary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Specialties
More internal medicine updates
- Long-acting injectable noninferior to oral HIV therapy in adherence trialOct 15, 2026
- Ponatinib-Blinatumomab Beats Imatinib-Chemotherapy in Ph-Positive ALL TrialOct 15, 2026
- Isoflurane sedation does not lower mortality in hypoxemic respiratory failureOct 14, 2026
- Trial finds higher mortality with intermittent vs continuous renal-replacement therapyOct 14, 2026
- No Overall Rise in Birth Defects With Early Benzodiazepine UseOct 13, 2026